Andrea Apolo

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Andrea Apolo
May 9, 2025, 06:22 | Blog
Petros Grivas: Thanks for your leadership Andrea Apolo and team
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Apr 26, 2025, 18:09 | Blog
Andrea Apolo: Join our 2025 BCAN team on May 3 to walk for bladder cancer awareness
Andrea Apolo, Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic at the National…
Mar 13, 2025, 05:31 | Blog
Regina Barragan-Carrillo: Latin American representation was strong at the PCF Early Career Thought Leaders
Regina Barragan-Carrillo, Postdoctoral fellow at the Genitourinary Clinic at the Medical Oncology and Medical Therapeutics…
Mar 11, 2025, 07:12 | Blog
Alex Zhu: GU Oncology Early Career Thought Leaders Conference
Alex Zhu, Society of Urologic Oncology fellow at the UW School of Medicine, posted on…
Mar 10, 2025, 14:47 | Blog
Sumanta Pal: The Prostate Cancer Foundation Oncology Early Career Thought Leaders meeting
Sumanta Pal, Medical Oncologist at City of Hope, shared a post on X: "The Prostate…
Feb 17, 2025, 08:41 | Blog
Andrea Apolo: Superp discussion by Tian Zhang of 3 important abstracts
Andrea Apolo, Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic at the National…
Feb 13, 2025, 07:07 | Blog
Michael Serzan: Thrilled to serve as Featured Voice for ASCO GU25
Michael Serzan, Genitourinary Medical Oncologist from Dana-Farber Cancer Institute, shared on X: "Thrilled to serve…
Jan 27, 2025, 15:54 | Blog
Katy Beckermann: We NEED the NIH to keep advancing research
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post by…
Jan 26, 2025, 08:59 | Blog
Andrea Apolo: We NEED the NIH and we NEED to continue to do our science
Andrea Apolo, Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic at the National…
Jan 26, 2025, 06:40 | Insight
Highlights from AUC3 by Shilpa Gupta
The Advanced Urologic Cancer Consensus Conference (AUC3), held on January 23-24, 2025, was a dynamic…
Jan 21, 2025, 06:28 | Blog
ASCO Thanks Drs. Bertagnolli, Rathmell for Their Service Leading NIH, NCI
Tian Zhang shared a post by ASCO, on X: "Two extraordinary women leaders of NIH…
Jan 17, 2025, 23:47 | Blog
From Lab to Clinic: The Power of Mentorship in Cancer Research - Train at NCI
Train at NCI shared a post on LinkedIn: "New Episode of Inside Cancer Careers! In celebration…
Jan 6, 2025, 12:15 | Insight
Erman Akkus: Adjuvant pembrolizumab after surgery in high risk muscle invasive bladder cancer
Erman Akkus, Medical Oncology fellow at Ankara University, Faculty of Medicine, shared a post on…
Jan 3, 2025, 21:19 | Insight
Advancements in urothelial carcinoma treatment - International Urology Cancer Summit
International Urology Cancer Summit shared a post on LinkedIn: "Advancements in urothelial carcinoma treatment. The latest…
Dec 27, 2024, 17:02 | Insight
Toni Choueiri: Top 10 GU Bladder/Kidney Cancer Trials for 2024
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Dec 24, 2024, 18:03 | Blog
Andrea Lancia: Excited to participate in the next GU Oncology Early Career Thought Leaders Conference!
Andrea Lancia, Associate Editor of Frontiers in Oncology, shared on LinkedIn: “Excited to participate in…
Dec 22, 2024, 17:03 | Science
Andrea Apolo: Several accruing Clinical Trials for patients with Small Cell Bladder Cancer
Andrea Apolo, Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic at the National…
Dec 8, 2024, 05:07 | Insight
Andrea Apolo: Calling GU junior faculty and fellows for the 2025 GU Early Career Thought Leaders conference
Andrea Apolo, Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic at the National…
Nov 6, 2024, 15:40 | Insight
Rana McKay: The perioperative use of ctDNA in localized prostate cancer
Rana McKay, Associate Professor of Medicine at UC San Diego, shared a post on X…
Nov 5, 2024, 17:59 | Insight
Guru Sonpavde: Meta-analysis of adjuvant PD1/L1 inhibitor immunotherapy in MIBC
Guru Sonpavde, Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida, shared a…
Nov 3, 2024, 12:59 | Insight
Uromigos Live24 panel on novel ADCs in urothelial carcinoma
Uromigos shared a post on X: “Don't get spooked by new data - watch the…
Oct 31, 2024, 15:39 | Blog
Tian Zhang: Looking forward to Alliance for Clinical Trials in Oncology fall meeting
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center,…
Oct 11, 2024, 17:45 | Blog
Andrea Apolo about the latest trials and practice changes in bladder cancer
Bogdana Schmidt, Urologic Oncologist at Huntsman Cancer Institute, shared a post about a conversation with…
Oct 11, 2024, 16:03 | Blog
Dimitra Rafailia Bakaloudi: The Uromigos trophy goes to TEAM USA
Dimitra Rafailia Bakaloudi shared a post on X: ''And the Uromigos trophy goes to TEAM…
Oct 7, 2024, 15:53 | Insight
Pembrolizumab vs. Observation in Muscle-Invasive Urothelial Carcinoma
Tres Uramigas shared on X: “Sure! Here’s the post without the usernames: AMBASSADOR: Phase III…
Sep 23, 2024, 15:50 | Insight
Guru Sonpavde: ESMO24 bladder cancer practice-changing highlight
Guru Sonpavde, Genitourinary Oncology and Phase I Clinical Trials Director of Chair of Bladder Cancer…
Sep 21, 2024, 13:04 | Blog
Guru Sonpavde: Adjuvant pembrolizumab improved outcomes in MIBC
Guru Sonpavde, Genitourinary Oncology and Phase I Clinical Trials Director of Chair of Bladder Cancer…
Sep 19, 2024, 07:37 | Blog
Patrizia Giannatempo: The benefit of adjuvant pembrolizumab with extended follow-up 45 months
Patrizia Giannatempo shared a post on X: "The AMBASSADOR trial confirms the benefit of adjuvant…
Sep 18, 2024, 14:14 | Blog
Petros Grivas: Ipilimumab/nivolumab vs standard care in non-clear cell renal cell cancer by Andrea Apolo
Petros Grivas shared a post by Andrea Apolo on X: "Agree with Andrea Apolo excellent…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 11:04 | Blog
Dr. Andrea Apolo's highlights from ESMO24 - Day 1
24th European Society for Medical Oncology (ESMO) Congress, a major event in the field of…
Sep 9, 2024, 14:16 | Blog
Tom Powles: Should Enfortumab Vedotin with Pembrolizumab be avoided due to baseline clinical conditions
Tom Powles shared a post on X, about recent paper published in ESMO Open: The…
Sep 5, 2024, 07:11 | Insight
David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma
David J. Benjamin, Hematology-Oncology specialist, shared a post on X: "Congratulations Andrea Apolo and colleagues on…
Aug 8, 2024, 10:16 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Andrea Apolo
We are excited to introduce Dr. Andrea Apolo, a leading expert in bladder cancer research…
Aug 4, 2024, 19:33 | Blog
Andrea Apolo: Proud to be part of this amazing panel on Women Leaders in GU oncology
Andrea Apolo, shared a post by Dan George, Director GU Oncology, Duke Cancer Institute, on X:…
Aug 4, 2024, 14:30 | Societies
8 Posts Not To Miss From GUWorld24!
The 2024 World Conference On Genitourinary Cancers (GUWorld24) took place from August 1st to 3rd…
Jul 8, 2024, 13:58 | Blog
Shilpa Gupta: Amazing multidisciplinary session on penile cancer
Shilpa Gupta shared on X: "Amazing multi-D session on penile cancer in Greece  The master Andrea…
Jul 5, 2024, 15:03 | Drugs
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours
Andrea Apolo, Chief of Bladder Cancer Section Genitourinary Malignancies Branch Center for Cancer Research at…
Jul 5, 2024, 13:47 | Insight
Andrea Apolo: Very proud of this Clinical Trial of Cabozantinib/Nivolumab published at JCO
Shilpa Gupta shared a post by Andrea Apolo, adding: "Huge congrats Andrea Apolo, leading this…
Jun 15, 2024, 05:45 | Blog
Mohammad Jad Moussa: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Apr 1, 2024, 19:03 | Blog
Top Influencers in GU Ocology by LARVOL
LARVOL shared on their X/Twitter page: "Delving into GU Oncology, we’re thrilled to spotlight the…
Jan 29, 2024, 14:47 | Blog
Roberto Iacovelli: Andrea Apolo at GU24 presented results of AMBASSADOR trial
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Oct 27, 2023, 04:48 | Insight
Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901
Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter: "Eloquent…
Oct 24, 2023, 14:57 | Blog
ESMO updates from Presidential Symposium- European Society for Medical Oncology (ESMO)
European Society for Medical Oncology (ESMO) shared on LinkedIn: "Positive outcomes in advanced or metastatic…
Oct 1, 2023, 12:45 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 6
In August, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion Leaders…
Aug 6, 2023, 18:56 | Blog
Why do we come to BCANTT? - Andrea Apolo
Why do we come to BCANTT? To get inspired by patients and amazing colleagues! To…
All: 46 Posts: 1 - 100
Special Coverage